Preliminary Injunction Granted Due to Weakened Invalidity Defense in Light of Inter Partes Review Decision

Sep 20, 2016

Reading Time : 1 min

The court considered four factors to determine whether the “drastic and extraordinary remedy” of a preliminary injunction was warranted. Beginning with the likelihood of success on the merits, the court only had to consider invalidity defenses. The defendants raised the obviousness ground that the PTAB had—for reasons of redundancy—declined to institute. The plaintiff’s challenges to the availability of this obviousness defense were unpersuasive to the court. Under recent Federal Circuit precedent, the defendants were not statutorily barred by estoppel under 35 U.S.C. § 315(e). Furthermore, the defendants were not precluded by common law issue preclusion. However, the court still found that the defendants were unlikely to prevail on the obviousness defense. The court also found that the defendants’ enablement defense was unlikely to prevail.

For the irreparable harm factor, the court found that the plaintiff had shown a real risk of being harmed by the defendants’ infringing technology if they were allowed to “capture and define” the developing and critically poised market for the technology at issue. The court then found that the balance of hardships factor weighed in favor of an injunction, and defendants’ alleged lost opportunities were the “price” of their conduct.

Finally, the court found that the public interest would be disserved without an injunction because laboratories, which grew to rely on potentially infringing technology, could end up facing liability of infringement.

Illumina, Inc. v. Qiagen, N.V., No. C 16-02788 WHA, 2016 WL 4719269 (N.D. Cal. Sept. 9, 2016) (Alsup, J.).

Share This Insight

Previous Entries

IP Newsflash

November 17,2025

The district of Delaware recently denied a defendant’s partial motion to dismiss pre-suit willful infringement from the litigation, finding instead that the allegations taken as a whole were sufficient to support pre-suit willfulness at the pleading stage. Specifically, the court found that the allegations as to the defendant’s involvement in a related foreign opposition proceeding and participation in the relevant industry were accompanied by detailed factual support that sufficiently pleaded willful infringement for the pre-suit period.

...

Read More

IP Newsflash

November 14, 2025

The Ninth Circuit recently reversed a district court’s decision to strike a plaintiff’s trade secret claims under the Defend Trade Secrets Act (DTSA) at the discovery stage. In doing so, the Ninth Circuit made clear that under the DTSA, whether a party defined their trade secret with sufficient particularity is a question of fact that generally does not lend itself to resolution in the absence of at least some discovery. This ruling contrasts with the California Uniform Trade Secrets Act (CUTSA), which requires a party to define their trade secrets with reasonable particularity before commencing discovery.

...

Read More

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.